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Moloney murine leukemia virus reverse transcriptase (MMLV RT) contains fingers, palm, 1 
thumb, and connection subdomains as well as an RNase H domain. The DNA polymerase 2 
active site resides in the palm subdomain, and the RNase H active site is located in the 3 
RNase H domain. The RNase H domain contains a positively charged α-helix called the 4 
C helix (H594GEIYRRR601), that is thought to be involved in substrate recognition. In this 5 
study, we expressed three versions of the RNase H domain in Escherichia coli, the wild-6 
type domain (WT) (residues Ile498−Leu671) and two variants that lack the regions 7 
containing the C helix (Ile593−Leu603 and Gly595−Thr605, which we called ΔC1 and 8 
ΔC2, respectively) with a strep-tag at the N-terminus and a deca-histidine tag at the C-9 
terminus. These peptides were purified from the cells by anion-exchange, Ni2+ affinity, 10 
and Strep-Tactin affinity column chromatography, and then the tags were removed by 11 
proteolysis. In an RNase H assay using a 25-bp RNA-DNA heteroduplex, WT, ΔC1, and 12 
ΔC2 produced RNA fragments ranging from 7 to 16 nucleotides (nt) whereas the full-13 
length MMLV RT (Thr24−Leu671) produced 14−20-nt RNA fragments, suggesting that 14 
elimination of the fingers, palm, thumb, and connection subdomains affects the binding 15 
of the RNase H domain to the RNA-DNA heteroduplex. The activity levels of WT, ΔC1, 16 
and ΔC2 were estimated to be 1%, 0.01%, and 0.01% of full-length MMLV RT activity, 17 
indicating that the C helix is important, but not critical, for the activity of the isolated 18 
RNase H domain.  19 
 20 
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Introduction 1 
 2 
Retroviral reverse transcriptase (RT) possesses RNA- and DNA-dependent DNA 3 
polymerase as well as RNase H activities. Moloney murine leukemia virus (MMLV) RT 4 
is a 75-kDa monomer, comprised of the fingers (Thr24−Asp124 and Phe156−Ser195), 5 
palm (Ile125−Phe155 and Pro196−Glu275), thumb (Gly276−Leu338), and connection 6 
(Pro339−Asp468) subdomains and an RNase H domain (Arg469−Leu671). The active 7 
site of the DNA  polymerase activity is located in the palm subdomain while the RNase 8 
H activity is in the RNase H domain [1, 2]. 9 
Due to its high catalytic activity and fidelity, MMLV RT is extensively used in cDNA 10 
synthesis [3]. Thermostability of DNA polymerase activity of MMLV RT increases by 11 
inactivating the RNase H activity by the mutation of the catalytically important residue, 12 
Asp524 [4-6]. The same strategy was successful to improve the thermostabilities of RTs 13 
from human immunodeficiency virus type-1 (HIV-1) [7] and avian myeloblastosis virus 14 
(AMV) [5, 8].  15 
The whole structure of MMLV RT has not been determined yet. From the crystal of 16 
full-length MMLV RT (Thr24−Leu671), the structures of the fingers, palm, thumb, and 17 
connection subdomains (Thr24−Asn479) have been determined, but that of the RNase H 18 
domain has not [1, 9]. On the other hand, from the crystal of the isolated RNase H domain, 19 
its whole structure has been determined [10]. In that study, the RNase H domain variant 20 
lacking the polypeptide Ile593-Leu603 was successfully crystallized, while the wild-type 21 
RNase H domain was not [10]. The deleted polypeptide region, Ile593-Leu603, contains 22 
a positively charged α-helix called the C helix (H594GEIYRRR601). In xenotropic murine 23 
leukemia virus-related virus (XMRV) RT, which has 95% amino-acid sequence homology 24 
  4 
with MMLV RT, like MMLV RT, the structure of the isolated RNase H domain has been 1 
determined whereas the whole structure has not [11-13]. Under these backgrounds, Das 2 
et al. [1] and Cote et al. [2] have proposed the structural model of MMLV RT that the 3 
RNase H domain is positioned far from the fingers/palm/thumb domain. However, 4 
Pandey et al. have proposed another model that the polypeptide region Pro480-Arg506 5 
of the RNase H domain, the structure of which has not been determined from the crystal 6 
of the full-length molecule or the RNase H domain, interacts with the fingers/palm/thumb 7 
subdomain, supporting the floor of the DNA polymerase active-site cleft. In MMLV RT, 8 
it is difficult to clarify the interaction between the DNA polymerase and RNase H active 9 
sites due to the lack of the crystal structure of the whole MMLV RT molecule.  10 
The expression and purification of the isolated RNase H domains of MMLV RT in 11 
Esherichia coli were previolusly reported [1, 14-16]. They were expressed without tags 12 
[14, 16] or S-transferase fusion protein [1, 15]. In this study, we describe expression, 13 
purification, and characterization of three versions of the RNase H domain of MMLV RT, 14 
the wild-type domain and the two C helix-deficient variants. They were expressed with 15 
N-terminal strep-tag and C-terminal deca-histidine tag in E. coli, purified from the cells, 16 
and then the tags were removed by proteolysis. The enzyme preparations thus obtained 17 
were characterized and compared with full-length MMLV RT. 18 
 19 




[γ-32P]dATP (111 TBq/mmol) was purchased from PerkinElmer (Waltham, MI). 24 
  5 
Oligonucleotides were from Fasmak (Atsugi, Japan). The RT concentration was 1 
determined by the method of Bradford [17] using Protein Assay CBB Solution (Nacalai 2 
Tesque, Kyoto, Japan) with bovine serum albumin (Nacalai Tesque) as standard.  3 
 4 
Plasmids   5 
  6 
We previously constructed the expression plasmid for C-teminally (His)6-tagged 7 
MMLV RT (pET-MRT) by inserting the C-teminally (His)6-tagged MMLV RT gene into 8 
the NdeI and EcoRI sites of pET-22b(+) plasmid (Merck Bioscience, Tokyo, Japan). The 9 
expression plasmids for the wild-type RNase H domain (Ile498−Leu671) (WT), its 10 
variant lacking Ile593-Leu603 (ΔC1), and its variant lacking Gly595−Thr605 (ΔC2), 11 
each with C-teminal (His)6 tag (pET22b-RNaseH-WT, pET22b-RNaseH-ΔC1, and 12 
pET22b-RNaseH-ΔC2, respectively) were constructed as follows. Site-directed 13 
mutagenesis was carried out using the following nucleotide primers 5’-14 
CAACACAACTGCCATATGATCCTGGCCGAA-3’ (497Nde) and 5’-15 
TTCGGCCAGGATCATATGGCAGTTGTGTTG-3’ (497Nde_cp) to change the 16 
nucleotide sequence CTTGAT encoding 496Leu497Asp into a NdeI recognition sequence 17 
CATATG. The resuting plasmid, pET-MRT(Nde), was digested with NdeI and self-ligated 18 
to produce the expression plasmid for WT, pET22b-RNaseH-WT. The 391-bp fragment 19 
(F1) was amplified from pET22b-RNaseH-WT using the following nucleotide primers 20 
5’-TAATACGACTCACTATAGGG-3’ (Pro) and 5’-21 
GCCTTCTGATGTGAGATGGGCAGTAGCAAA-3’ (DelI593-L603rev-4), and the 247-22 
bp fragment (F2) was amplified using the following nucleotide primers 5’- 23 
TTTGCTACTGCCCATCTCACATCAGAAGGC-3’ (DelI593-L603for-4) and 5’-24 
  6 
CTGAATTCTAGTGGTGATGGTGGTGGTGGAGGAGGGTAGAGGTGT-3’ (MRT-1 
HISB). The 608-bp fragment was amplified using the nucleotide primers Pro and MRT-2 
HISB from the mixture of F1 and F2, digested with the restriction enzymes XbaI and 3 
EcoRI, and inserted in pET-22b(+) digested with XbaI and EcoRI to produce the 4 
expression plasmid for ΔC1, pET22b-RNaseH-ΔC1. The expression plasmid for ΔC2, 5 
pET22b-RNaseH-ΔC1 was constructed by the same method but using the nucleotide 6 
primers 5’-CTCTTTGCCTTCTGATGTGAGATGGGCAGT-3’ (DelG595-T605rev-4) 7 
and 5’-ACTGCCCATATCCATTCAGAAGGCAAAGAG-3’ (DelG595-T605for-4) 8 
instead of DelI593-L603rev-4 and DelI593-L603for-4, respectively.  9 
The expression plasmids for WT, ΔC1, and ΔC2, each with an N-terminal strep tag 10 
and a C-teminal (His)10 tag (pET52b-RNaseH-WT, pET52b-RNaseH-ΔC1, and pET52b-11 
RNaseH-ΔC2, respectively) were constructed as follows. The 550-bp fragment was 12 
amplified with the following nucleotide primers 5’-13 
TTTTGGTACCTTGATGTCCTGGCCGAAGCC-3’ (497Kpn) and 5’-14 
TTTTGAGCTCGAGGAGGGTAGAGGTGTC-3’ (671Sac) from pET22b-RNaseH-WT, 15 
and the 517-bp fragments were amplified from 497Kpn and 671Sac from pET22b-16 
RNaseH-ΔC1 or pET22b-RNaseH-ΔC2. These three fragments  were digested with the 17 
restriction enzymes KpnI and SacI, and inserted in pET-52b(+) (Merck Bioscience) to 18 
produce pET52b-RNaseH-WT, pET52b-RNaseH-ΔC1, and pET52b-RNaseH-ΔC2, 19 
respectively. 20 
 21 
Expression and purification of recombinant RNase H domain  22 
 23 
E. coli strain BL21(DE3) [F-, ompT, hsdSB (rB -mB -) gal dcm (DE3)] was transformed 24 
  7 
with either pET52b-RNaseH-WT, pET52b-RNaseH-ΔC1, or pET52b-RNaseH-ΔC2. The 1 
overnight culture of the transformants (20 ml) was added to 2,000 ml of LB broth and in 2 
a 2-liter flask and incubated at 37°C under vigorous aeration by air-pump. When OD660 3 
reached 0.6–0.8, 0.5 mL of 0.5 M IPTG was added and growth was continued at 30ºC for 4 
4 h. After centrifugation at 10,000 × g for 10 min, the cells were harvested, suspended 5 
with 20 ml of 0.02 M potassium phosphate (pH 7.2), 2.0 mM dithiothreitol (DTT), 10% 6 
glycerol (buffer A) containing 1 mM phenylmethylsulfonyl fluoride (PMSF) and 7 
disrupted by sonication. After centrifugation at 20,000 × g for 40 min, the supernatant 8 
was collected and applied to a column [25 mm (inner diameter) × 120 mm] packed with 9 
Toyopearl DEAE-650M gel (Tosoh, Tokyo, Japan), previoulsy equilibrated with buffer A. 10 
The bound RNase H domain was eluted with buffer A containing 100 mM NaCl and 11 
applied to a HisTrap column, previously equilibrated with 50 mM Tris-HCl (pH 8.3), 200 12 
mM KCl, 2.0 mM DTT, 10% glycerol (buffer B). The bound RNase H domain was eluted 13 
with buffer B containing 250 mM imidazole and applied to a Strep-Tactin Superflow 14 
column (IBA, Göttingen, Germany), previously equilibrated with 100 mM Tris-HCl (pH 15 
8.0), 150 mM NaCl, 1 mM EDTA (buffer C). The bound RNase H domain was eluted 16 
with buffer C containing 2.5 mM desthiobiotin, 50% glycerol. Two mg of the obtained 17 
RNase H domain was subjected to the digestion by 10 units of HRV 3C protease 18 
(Accelagen, San Diego, CA) to cleave the strept tag and 50 units of thrombin (GE 19 
Healthcare) to cleave the (His)10 tag in 12.5 ml of 40 mM Tris-HCl (pH 7.5), 120 mM 20 
NaCl, 10% glycerol at 4°C for 36 h (buffer D). Then, the solution was three-fold diluted 21 
by adding 25 ml of water and further incubated at 4°C for 36 h. The digest was applied 22 
to a HisTrap column, previously equilibrated with buffer B. The RNase H domain without 23 
tags had weak binding ability to a HisTrap column, and it was collected from a HisTrap 24 
  8 
column by eluting with buffer B containing 50 mM imidazole. In this buffer condition, 1 
the RNase H domain with deca-histidine tag was not eluted. The obtained RNase H 2 
domain without tags was applied to a PD-10 column packed with a Sephadex G-25 (GE 3 
Healthcare), previously equilibrated with 20 mM Tris-HCl (pH 7.0), containing 200 mM 4 
NaCl, 2.0 mM DTT, and 10% glycerol. The column was washed and eluted with the same 5 




SDS-PAGE of the RNase H domain was carried out in a 12.5% polyacrylamide gel 10 
under reducing conditions. Proteins (1.2 µg) were reduced by treatment with 2.5% (v/v) 11 
of 2-mercaptoethanol at 100ºC for 10 min, and then applied onto the gel. A constant 12 
current of 40 mA was applied for 40 min. After electrophoresis, proteins were stained 13 
with Coomassie Brilliant Blue R-250. The molecular mass marker kit consisting of rabbit 14 
muscle phosphorylase B (97.2 kDa), bovine serum albumin (66.4 kDa), hen egg white 15 
ovalbumin (44.3 kDa), and bovine carbonic anhydrase (29.0 kDa) was purchased from 16 
Takara Bio Inc (Otsu, Japan). 17 
 18 
CD spectroscopy 19 
 20 
The CD spectra of the RNase H domain was measured with a 2-mm cell using a J-21 
820 spectropolarimeter (Jasco, Tokyo, Japan) under the following condition: spectral 22 
range 200-250 nm; 25ºC; 100 nm min-1 scan rate; and 10 accumulations. 23 
 24 
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Fluorescence-based RNase H assay 1 
 2 
Fluorescence-based RNase H activity assay was carried out according to the method 3 
by Parniak et al [18]. Briefly, an RNA/DNA hybrid (named R18/D18) was prepared by 4 
mixing the 3’-fluorescein modified 18-nucleotide (nt) RNA 5’-5 
GAUCUGAGCCUGGGAGCU-3’ (R18) and 5’-dabcyl-modified complementary 18-nt 6 
DNA (D18) with a molar ratio of 1.0:1.2 in 50 mM Tris-HCl buffer (pH 8.0) containing 7 
60 mM KCl followed by the incubation at room temperature for 30 min. The RNase H 8 
reaction was carried out in 50 mM Tris-HCl buffer (pH 8.0) containing 60 mM KCl, 5.0 9 
mM MgCl2, 0.25 µM R18/D18 (the concentration is expressed as that of R18), and 10 
indicated concentrations of the RNase H domain or the full-length MMLV RT at 37ºC. 11 
An aliquot (800 µl) was taken from the reaction mixture at a predetermined time and 12 
added to 0.5 M EDTA (160 µl). The fluorescence spectra of the reaction products were 13 
measured with a Shimadzu RF-5300PC fluorescence spectrophotometer (Shimadzu, 14 
Kyoto, Japan) under the following conditions: excitation wavelength, 490 nm; spectral 15 
range 500-600 nm; 25ºC; 120 nm min-1 scan rate; and 3 accumulations. In each 16 
measurement, the control baseline was obtained with the corresponding buffer in the 17 
absence of protein.  18 
 19 
Radioisotope-based RNase H assay 20 
 21 
Radioisotope-based RNase H activity assay was carried out according to the method 22 
by Álvarez et al [19]. Briefly, an RNA/DNA hybrid (named R25/D25) was prepared by 23 
mixing 5’-[32P]-labelled 25-nt RNA 5’-AUGUAUAGCCCUACCAGCAUUCTGG-3’ 24 
  10 
(R25) and unlabelled complementary 25-nt DNA (D25) by the method above described. 1 
The RNase H reaction (40 µl) was carried out in 50 mM Tris–HCl (pH 8.0) buffer, 2 
containing 50 mM KCl, 0.1 mM MgCl2, 20 nM R25/D25, and indicated concentrations 3 
of the RNase H domain or the full-length MMLV RT at 37ºC. An aliquot (4 µl) was taken 4 
from the reaction mixture at a predetermined time and added to 4 µl of sample-loading 5 
buffer (10 mM EDTA, 90% (v/v) formamide, 3 mg/ml xylene cyanol FF, 3 mg/ml 6 
bromophenol blue, and 50 µM 31D/21D. (31D/21D was prepared by mixing unlabelled 7 
31-nt DNA 5’-TTTTTTTTTAGGATACATATGGTTAAAGTAT-3’ (D31) and unlabelled 8 
complementary complementary 21-nt DNA 5’-ATACTTTAACCATATGTATCC-3’(D21) 9 
by the method above described and used as a carrier DNA.) The RNA fragments of the 10 
reaction products were analyzed by denaturing 20% polyacrylamide gel electrophoresis 11 
followed by image scanning with a BAS-2500 scanner (Fujifilm, Tokyo, Japan) using the 12 




Expression and purification of the RNase H domain 17 
 18 
We initially attempted to express the wild-type RNase H domain (WT) 19 
(Ile498−Leu671) and the two C helix-deficient variants lacking Ile593-Leu603 (ΔC1) and 20 
Gly595-Thr605 (ΔC2), with C-terminal (His)6 tags at the C-terminus. We constructed 21 
three expression plasmids, pET22b-RNaseH-WT, pET22b-RNaseH-ΔC1, and pET22b-22 
RNaseH-ΔC2 that contain the T7 promoter, an ATG initiation codon, a 540- or 507-bp 23 
sequence encoding 180 or 169 amino acids comprising the intact or C helix-deficient 24 
  11 
RNase H domain (Ile498−Leu671), and a (His)6 tag, and a stop codon. SDS-PAGE 1 
analysis of the soluble fractions of the E. coli transformants showed a 20-kDa protein 2 
band corresponding to WT or a 19-kDa protein band corresponding to ΔC1 and ΔC2 (data 3 
not shown). However, the RNase H domain could not be purified to homogeneity because 4 
several contaminating proteins, presumably C-terminal (His)6-tagged RNase H domain 5 
degradation products, could not be completely removed (data not shown).  6 
Next we attempted to express WT, ΔC1, and ΔC2 with both an N-terminal strep tag 7 
and a C-terminal (His)10 tag. We constructed three expression plasmids, pET52b-8 
RNaseH-WT, pET52b-RNaseH-ΔC1, and pET52b-RNaseH-ΔC2 (Fig. 1), that contain 9 
the T7 promoter, an ATG initiation codon, a 711- or 678-bp sequences encoding 237 or 10 
206 amino acids comprising a strep-tag, an HRV 3C protease recognition site, the intact 11 
or C helix-deficient RNase H domain, a thrombin recognition site, and a (His)10 tag, and 12 
a stop codon. SDS-PAGE analysis of the soluble fractions showed a 25-kDa protein band 13 
corresponding to WT in the transformants with pET52b-RNaseH-WT (lane 2 in Fig. 2A) 14 
and a 24-kDa protein band corresponding to ΔC1 or ΔC2 in the transformants with 15 
pET52b-RNaseH-ΔC1 or pET52b-RNaseH-ΔC2, respectively (data not shown).   16 
To purify WT, ΔC1, and ΔC2, we used anion-exchange chromatography as the first 17 
step, the Ni2+-sepharose chromatography as the second step, and the Strep-Tactin affinity 18 
chromatography as the third step. At each step, each fraction was tested for the presence 19 
of the 25-kDa or 24-kDa protein band by SDS-PAGE, and the active fractions were 20 
pooled based on coomassie staining. The SDS-PAGE analysis showed that the active 21 
fractions from the WT purification exhibited 25-kDa protein bands (Fig. 2A), and the 22 
purified preparations of WT, ΔC1, and ΔC2 exhibited 25-kDa or 24-kDa protein bands 23 
(Fig. 2B). In Fig. 2B, the 50 or 55 kDa faint bands were also observed; however their 24 
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orgins were unknown. Then, the N-terminal strep tag and C-terminal (His)10 tag were 1 
removed by successive proteolysis with HRV 3C protease and thrombin, respectively. 2 
After proteolysis, the WT preparation exhibited a single 22-kDa protein band (Fig. 2C), 3 
the ΔC1 and ΔC2 preparations exhibited single 21-kDa protein bands (data not shown), 4 
and the protein bands corresponding to the 50 or 55 kDa faint bands obserbed in Fig. 2B 5 
were not observed (Fig. 2C for WT and and data not shown for ΔC1 and ΔC2). From the 6 
2 L cultures, 0.5−1.0 mg of purified WT, ΔC1, and ΔC2 were obtained. In 20 mM Tris-7 
HCl (pH 7.0), 200 mM NaCl, 2.0 mM DTT, and 10% glycerol, WT, ΔC1, and ΔC2 with 8 
tags could be concentrated to 1−2 mg/ml, whereas without tags, these proteins could be 9 
concentrated to 10 mg/ml (data not shown), indicating that the removing of the tags 10 
increased the solubility. 11 
To examine if the deletion of Ile593-Leu603 or Gly595-Thr605 affects structural 12 
change of the isolated RNase H domain, we made spectroscopic analyses. UV 13 
spectroscopy showed that purified WT, ΔC1, and ΔC2 exhibited spectra with a deep 14 
trough at approximately 250 nm and a peak at 275 nm (Fig. 3B for WT and data not 15 
shown for ΔC1 and ΔC2). CD spectroscopy showed that purified WT, ΔC1, and ΔC2 16 
exhibited negative ellipticities at 202–250 nm with peaks at approximately 208 nm and 17 
222 nm (Fig. 3B for WT and data not shown for ΔC1 and ΔC2). No appreciable changes 18 
were observed in UV and CD) spectra, suggesting that ΔC1, and ΔC2 did not suffer from 19 
any global or drastic structural changes by the deletion.  20 
 21 
Characterization of the RNase H domain 22 
 23 
To analyze the RNase H activity of the isolated RNase H domains, we performed 24 
  13 
fluorescence-based RNase H assay. An RNA/DNA hybrid (called R18/D18) consisting 1 
of a 3’-fluorescein modified 18-nt RNA (R18) and a 5’-dabcyl-modified 18-nt DNA 2 
(D18) was used as the substrate (Fig. 4A). R18/D18 is designed to emit strong 3 
fluorescence when R18 is cleaved at a site close to the 3’ end, and the fluorescein-labeled 4 
RNA fragment dissociates from the complementary DNA strand. Figure 4B shows the 5 
difference in the fluorescence spectra of R18/D18 before and after the reaction. Based on 6 
the previous report, the MgCl2 concentration was set at 5.0 mM [19]. When R18/D18 was 7 
incubated without the full-length RT or the isolated RNase H domain for 30 min, there 8 
was no change in the fluorescence spectra. When R18/D18 was incubated with 50 nM 9 
HIV-1 RT or 1.8 µM WT for 30 min, the fluorescence increased with the peak at 515 nm. 10 
When R18/D18 was incubated with ΔC1 or ΔC2 for 30 min, no fluorescence increase was 11 
observed. These results suggest that WT has RNase H activity and ΔC1 and ΔC2 do not.   12 
To further analyze the RNase H activity of the isolated RNase H domains, we used 13 
a radioisotope-based RNase H assay. An RNA/DNA hybrid (R25/D25) consisting of a 5’-14 
[32P]-labelled 25-nt RNA (R25) and an unlabeled complementary DNA (D25) was used 15 
as the substrate (Fig. 5A). After the RNase H reaction, the RNA reaction products were 16 
analyzed by denaturing PAGE. First we examined the effects of MgCl2 concentration on 17 
the RNase H activity of WT and found that reactions containing 0.1−0.2 mM yielded 18 
relatively higher amounts of products than those containing other concentrations (0−15 19 
mM) (data not shown). Thus, 0.1 mM was used in subsequent experiments.  20 
Figure 5B shows the denatured PAGE analysis of the products obtained from the 21 
reaction under various conditions. Unreacted R25/D25 showed only a single 25-nt RNA 22 
band. When R25/D25 was incubated with 30 nM full-length MMLV RT, 16−20-nt bands 23 
were detected at 15 s, and 14−17-nt bands were detected at 10 min. When R25/D25 was 24 
  14 
incubated with 30 nM WT, only a 25-nt band was detected at both 15 s and 10 min. When 1 
R25/D25 was incubated with 1.0 or 10 µM WT, only a 25-nt band was detected at 15 s, 2 
whereas various bands (mainly 7−16-nt bands) were detected at 10 min. This indicated 3 
that the cleavage pattern of WT was different from that of the full-length MMLV RT and 4 
that the activity of WT was considerably weaker than that of the full-length MMLV RT. 5 
When R25/D25 was incubated with ΔC1 or ΔC2, various bands (mainly 7−16-nt bands) 6 
were only detected at a 10 µM and 10 min. Under all other reaction conditions tested, 7 
only the uncleaved 25-nt band was detected. This indicated that although the activities of 8 
ΔC1 and ΔC2 were weaker than that of WT, the cleavage patterns were the same as that 9 
of WT.  10 
Figure 5C compares the time courses of the cleavage patterns obtained in the 11 
reactions with 30 nM full-length MMLV RT, 1 µM WT, and 10 µM ΔC1 and ΔC2. The 12 
results of a densitometry trace of each band were shown in Fig. S1. In full-length MMLV 13 
RT, 10−20-nt bands were detected, in which the amount of the 17-nt band was the highest 14 
at 5-30 min and that of the 14-nt band was the highest at 60 and 120 min. In WT, ΔC1, 15 
and ΔC2, 7−20-nt bands were detected, in which the amount of the 7- or 10-nt band was 16 
higher than those of other bands. The rates of the decrease in the 25-nt bands in the 17 
reaction with WT, ΔC1, and ΔC2 were 30%, 3%, and 3% of full-length MMLV RT, 18 
respectively. Based on these enzyme concentrations (30 nM for full-length MMLV RT, 1 19 
µM for WT, and 10 µM for ΔC1, and ΔC2), the activities of WT, ΔC1, and ΔC2 were 20 
roughly estimated to be 1%, 0.01%, and 0.01% of full-length MMLV RT activity, 21 
respectively.     22 
 23 
  15 
Discussion 1 
 2 
We expressed the isolated RNase H domain of MMLV RT with N-terminal strep-tag 3 
and C-terminal deca-histidine tag. The use of two tags has an advantage as it allows the 4 
removal of degraded products using one of the tags. In our initial attempt to express the 5 
RNase H domain with only a C-terminal (His)6-tag, the degraded products could not be 6 
completely removed, as described in the Results section. In addition, the removing of the 7 
tags was important because it increased the solubility. Based on the SDS-PAGE (Fig. 2) 8 
and spectroscopic analysis (Fig. 3) results, we considered the purity of the RNase H 9 
preparations to be sufficient for use in structural and functional analysis.  10 
The DNA in the 25-bp RNA/DNA heteroduplex used in the radioisotope-based 11 
RNase H assay lacks the primer 3’-terminus (Fig. 5A). The reaction with full-length 12 
MMLV RT produced 17−20-nt RNA fragments (Fig. 5B), indicating that the position at 13 
which the RNA strand of the RNA/DNA hybrid is cleaved is 17−20 bp upstream of the 14 
3’-terminus of the primer. This is the same position as previoulsly reported in assays of 15 
full-length MMLV RT using RNA/DNA hybrids with primer 3’-termini [20, 21]. This 16 
suggests that the DNA polymerase active site binds to the RNA/DNA hybrid in a similar 17 
manner whether it has the primer 3’-terminus or not.  18 
Unlike the full-length MMLV RT, WT, ΔC1, and ΔC2 produced RNA fragments 19 
mainly ranging from 7 to 16 nt in length (Fig. 5B). We speculate a possible mechanism 20 
for the generation of fragments of these lengths as follows: For the full-length MMLV 21 
RT, the position at which the RNase H active site binds to the RNA strand of an 22 
RNA/DNA hybrid is predetermined, whereas for the isolated RNase H domains, the 23 
active site binding position is not; thus the cleavage site by the isolated RNase H domain 24 
  16 
is different from that by the full-length MMLV RT. This suggests that elimination of the 1 
fingers, palm, thumb, and connection subdomains affects the binding of the RNase H 2 
domain to an RNA/DNA heteroduplex. 3 
In this study, we expressed WT as well as ΔC1 and ΔC2 because the crystal structure 4 
of MMLV RT ΔC1 has been determined [1] and the structures of XMRV RT WT and ΔC2 5 
have been determined [22, 23]. In the RNase H assay using a fluorescent substrate, WT 6 
exhibited activity, whereas ΔC1 and ΔC2 did not (Fig. 4). However, in the RNase H assay 7 
using a radioactive substrate, all three exhibited the activity (Fig. 5). Therefore, we 8 
concluded that the C helix is not critical for the activity of the isolated MMLV RT RNase 9 
H domain. However, the RNase H activities of ΔC1 and ΔC2 were only 10% of WT 10 
activity (Fig. 5C), suggesting that the C helix is important for activity. Similar results have 11 
been reported for full-length MMLV RT, and the C helix has been shown to be important 12 
for both DNA polymerase and RNase H activities [22, 23].  13 
Unlike the MMLV RT RNase H domain, the RNase H domain of HIV-1 RT does not 14 
contain the C helix, and the isolated HIV-1 RT RNase H domain lacks activity [24-27]. 15 
Interestingly, insertion of a basic loop near at the active site of the isolated RNase H 16 
domain generated weak activity in the presence of Mn2+ [28]. Recently, Permanasari et 17 
al. reported that addition of bacterial RNase HI or HII substrate binding domain to the 18 
isolated RNase H domain also resulted in weak activity in the presence of Mn2+ [29]. 19 
These results supports the notion that the C helix is important for RNase H activity. 20 
E. coli RNase HI contains the C helix [30] whereas the RNase H domains of MMLV 21 
RT and HIV-1 RT are C helix-deficient. Comparison of the structure of ΔC1 (PDB 22 
accession codes SHB5) with that of E. coli RNase HI (3AA2) suggests that the C helix of 23 
the RNase H domain of MMLV RT is positioned similary to that of E. coli RNase HI. 24 
  17 
Comparison of the structure of ΔC1 with a complex containing the isolated HIV-1 RT 1 
RNase H domain and an RNA/DNA heteroduplex (1HYS) suggests that the C helix in the 2 
RNase H domain of MMLV RT interacts with the RNA strand of the RNA/DNA 3 
heteroduplex. Therefore, the C helix is thought to contribute to substrate recognition, as 4 
reported previously by Nowotny et al. [31].  5 
In conclusion, we expressed the RNase H domain of MMLV RT in E. coli and 6 
purified it to homogeneity. Characterization of the recombinant proteins suggested that 7 
the C helix is involved in the substrate recognition and that the fingers, palm, thumb, and 8 
connection subdomains are involved in positioning of the cleavage sites in the RNA strand 9 
of an RNA/DNA heteroduplex. These recombinant RNase H domain proteins might be 10 
suitable for use in structural and functional analyses to elucidate the mechanisms of 11 
thermostabilization of MMLV RT through site-directed mutagenesis. An extensive study 12 
is currently underway to prepare crystals of WT, ΔC1, and ΔC2, with and without a 13 
mutation of the catalytic Asp (Asp524).  14 
 15 
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Figure legends 1 
 2 
Fig. 1. Expression plasmids for the RNase H domain. The structures of pET-RNaseH-WT, 3 
pET-RNaseH-ΔC1, and pET-RNaseH-ΔC2 are shown. The “498”, “671”, and asterisk 4 
indicate Ile498, Leu671, and the termination codon. The amino acid sequences of strep 5 
tag, HRV 3C protease recognition site, thrombin recognition site, and (His)10 are 6 
underlined.   7 
 8 
Fig. 2. SDS-PAGE analysis. CBB-stained 12.5% SDS-polyacryl amide gel is shown. (A) 9 
Active fractions of each purification stage for the wild-type RNase H (WT). Lanes: 10 
marker proteins (lane 1), soluble fractions of the total extracts (lane 2), active fractions of 11 
ion-exchange chromatography (lane 3), Ni2+ affinity chromatography (lane 4), and Strep-12 
Tactin affinity chromatogaraphy (lane 5). (B) Purified enzyme preparations with N-13 
terminal strep tag and C-terminal (His)10 tag. Lanes: marker proteins (lane 1), WT (lane 14 
2), RNaseH-ΔC1 (lane 3), and RNaseH-ΔC2 (lane 4). (C) Purified WT preparations. 15 
Lanes: marker proteins (lane 1), before removal of fused tags (lane 2), and after removale 16 
of fused tags (lane 3).   17 
 18 
Fig. 3. UV and CD spectroscopic analysis of purified WT. (A) UV spectra. (B) CD spectra.  19 
 20 
Fig. 4. RNase H activity of the RNase H domain using a fluorescent substrate. (A) 21 
Sequences of the RNA-DNA hybrid, R18/D18. (B) Fluorescence spectra of R18/D18 with 22 
excitation at 490 nm. The reaction was carried out with either of 50 nM HIV-1 RT, 1.8 23 
µM WT, 1.8 µM ΔC1, and 1.8 µM ΔC2 for 30 min at pH 8.0 at 37ºC. 24 
  23 
 1 
Fig. 5. RNase H activity of the RNase H domain using a radioactive substrate. (A) 2 
Sequences of the RNA-DNA hybrid, R25/D25. (B, C) Patterns of denatured PAGE. The 3 
enzyme concentrations were 30 nM for full-length MMLV RT, 1 µM for WT, and 10 µM 4 
for ΔC1 and ΔC2. The reaction times were 15 s and 10 min (B) and 15 s, 30 s, 1 min, 5 5 
min, 15 min, 30 min, 1 h, and 2 h (C). The reaction was carried out with 1.8 µM WT, 6 
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Fig. S1. Time course of the amounts of RNA fragments in the RNase H reaction. The 
result of the densitometry traces of the bands in Fig. 5C is shown. The relative intensity is 
defined as the ratio of the amount of each band to those of all 7−25-nt bands. Symbols for 
RNA fragments (nt): 25 (open circle), 20 (open triangle), 19 (open square), 18 (open 
diamond), 17 (solid circle), 16 (solid triangle), 15 (solid square), 14 (solid diamond), 13 
(gray circle), 12 (gray triangle), 10 (gray square), and 7 (gray diamond). 
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